PARIS, I0
Allocation by class
Portfolio Concentration
Top 3 weight
63.5%
Top 10 weight
100.0%
Voting Authority Distribution
Total shares with voting rights: 30.52M
Full voting authority
30.52M
shares
Joint voting authority
0.00
shares
No voting authority
0.00
shares
Investment Discretion (by position count)
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
MeiraGTx Holdings plcSOLE | COM | 12.20M | SH | $164.79M 30.86% | 12.20M | 0.00 | 0.00 |
Inhibrx Biosciences, Inc.SOLE | COM | 1.16M | SH | $109.71M 20.54% | 1.16M | 0.00 | 0.00 |
NovavaxSOLE | COM NEW | 6.88M | SH | $64.81M 12.14% | 6.88M | 0.00 | 0.00 |
AnaptysBioSOLE | COM | 821.92K | SH | $55.48M 10.39% | 821.92K | 0.00 | 0.00 |
Odyssey Therapeutics Inc.SOLE | COMMON STOCK | 1.99M | SH | $37.27M 6.98% | 1.99M | 0.00 | 0.00 |
Agomab Therapeutics NVSOLE | SPONSORED ADS | 2.78M | SH | $36.12M 6.76% | 2.78M | 0.00 | 0.00 |
MapLight Therapeutics Inc.SOLE | COM | 912.04K | SH | $32.69M 6.12% | 912.04K | 0.00 | 0.00 |
First Tracks Biotherapeutics Inc.SOLE | ORD SHS | 821.92K | SH | $16.54M 3.10% | 821.92K | 0.00 | 0.00 |
Immuneering CorpSOLE | CLASS A COM | 2.71M | SH | $13.52M 2.53% | 2.71M | 0.00 | 0.00 |
Q32 Bio Inc.SOLE | COM | 244.08K | SH | $3.11M 0.58% | 244.08K | 0.00 | 0.00 |